TACROLIMUS capsule 미국 - 영어 - NLM (National Library of Medicine)

tacrolimus capsule

cardinal health - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 1 mg

TACROLIMUS SANDOZ tacrolimus 2 mg capsule blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

tacrolimus sandoz tacrolimus 2 mg capsule blister pack

sandoz pty ltd - tacrolimus monohydrate, quantity: 2.044 mg (equivalent: tacrolimus, qty 2 mg) - capsule - excipient ingredients: hypromellose; croscarmellose sodium; magnesium stearate; gelatin; titanium dioxide; iron oxide yellow; iron oxide red; brilliant blue fcf; lactose monohydrate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

TACROLIMUS SANDOZ tacrolimus 0.75 mg capsule blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

tacrolimus sandoz tacrolimus 0.75 mg capsule blister pack

sandoz pty ltd - tacrolimus monohydrate, quantity: 0.767 mg (equivalent: tacrolimus, qty 0.75 mg) - capsule - excipient ingredients: hypromellose; croscarmellose sodium; magnesium stearate; gelatin; titanium dioxide; iron oxide yellow; brilliant blue fcf; lactose monohydrate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

PHARMACOR TACROLIMUS tacrolimus 0.5 mg capsule blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pharmacor tacrolimus tacrolimus 0.5 mg capsule blister pack

pharmacor pty ltd - tacrolimus monohydrate, quantity: 0.51 mg (equivalent: tacrolimus, qty 0.5 mg) - capsule - excipient ingredients: dichloromethane; ethanol absolute; hypromellose; magnesium stearate; croscarmellose sodium; lactose; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

PHARMACOR TACROLIMUS tacrolimus 5 mg capsule blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pharmacor tacrolimus tacrolimus 5 mg capsule blister pack

pharmacor pty ltd - tacrolimus monohydrate, quantity: 5.1 mg (equivalent: tacrolimus, qty 5 mg) - capsule - excipient ingredients: lactose; dichloromethane; croscarmellose sodium; hypromellose; ethanol absolute; magnesium stearate; titanium dioxide; purified water; iron oxide red; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

PHARMACOR TACROLIMUS tacrolimus 1 mg capsule blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pharmacor tacrolimus tacrolimus 1 mg capsule blister pack

pharmacor pty ltd - tacrolimus monohydrate, quantity: 1.02 mg (equivalent: tacrolimus, qty 1 mg) - capsule - excipient ingredients: hypromellose; magnesium stearate; dichloromethane; lactose; ethanol absolute; croscarmellose sodium; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

ASTAGRAF XL- tacrolimus extended-release capsules capsule, coated, extended release 미국 - 영어 - NLM (National Library of Medicine)

astagraf xl- tacrolimus extended-release capsules capsule, coated, extended release

astellas pharma us, inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.5 mg - astagraf xl® is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients who can swallow capsules intact [see use in specific populations (8.4) and clinical studies (14.1), (14.2)]. astagraf xl is contraindicated in patients with known hypersensitivity to tacrolimus [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy registry that monitors pregnancy outcomes in women exposed to astagraf xl during pregnancy. the transplantation pregnancy registry international (tpri) is a voluntary pregnancy exposure registry that monitors outcomes of pregnancy in female transplant recipients and those fathered by male transplant recipients exposed to immunosuppressants including tacrolimus. healthcare providers are encouraged to advise their patients to register by contacting the transplantation pregnancy registry international at 1-877-955-6877 or https://www.transplantpregnancyregistry.org/. risk

TACROLIMUS capsule 미국 - 영어 - NLM (National Library of Medicine)

tacrolimus capsule

watson laboratories, inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 5 mg

TACROLIMUS capsule gelatin coated 미국 - 영어 - NLM (National Library of Medicine)

tacrolimus capsule gelatin coated

bryant ranch prepack - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 1 mg

PROTOPIC- tacrolimus ointment 미국 - 영어 - NLM (National Library of Medicine)

protopic- tacrolimus ointment

astellas pharma us inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 0.3 mg in 1 g - protopic ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy  for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. protopic ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). protopic (tacrolimus) ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.